Related Experiment Video
Updated: May 31, 2026

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
Published on: November 24, 2021
Study of pharmacokinetics and tissue distribution of liposomal brucine for dermal administration
Bai-Can Yang1, Zhi-Feng Chu, Sha Zhu
1Pharmacy Department of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China. ybc2002@sina.com
Objective:
To evaluate the pharmacokinetics and tissue distribution of liposomal brucine (LB) for dermal application.
Methods:
Pharmacokinetics and tissue distribution were studied by in vivo animal testing. High performance liquid chromatography (HPLC) was used to detect the concentration of brucine in rats' skin, plasma and various tissues.
Results:
After dermal administration, LB was absorbed rapidly in the skin and could be detected after 0.5 hours. After 36 hours, levels were too low to be detected. In plasma, levels were also too low to be detected after 36 hours. The concentration of LB reached 50% of the maximum in all tissues except the brain, peaking after 1.5 hours but still detectable after 12 hours.
Conclusion:
The concentration of LB was high in skin at the application site. LB was quickly absorbed into tissues through the blood circulation and widely distributed throughout the whole body. There was no obvious toxicity and LB did not readily accumulate in tissues and organs. It showed local potency but low overall systemic toxicity.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Drug Distribution: Tissue Binding
For...
Modified-Release Drug Delivery Systems: Bioavailability
Bioavailability Study Design: Single Versus Multiple Dose Studies

